Navigation Links
New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures

Data Presented at the American Academy of Neurology Annual Meeting Show Approximately 50 Percent Reduction in Partial Seizures

BOSTON, May 01, 2007 /PRNewswire/ -- Data from two clinical trials presented today at the American Academy of Neurology (AAN) meeting suggest that an investigational once daily extended release formulation of Lamictal(R) (lamotrigine) is effective as add-on treatment in patients with partial epilepsy with and without secondary generalization. Lamictal XR Extended- Release Tablets are currently in development for the treatment of epilepsy. If approved, it will be the first extended release, new generation epilepsy treatment taken once-daily.

Data from the ARMOR study, an international, multi-center, randomized, double-blind, placebo-controlled trial, showed that the new once-daily, extended release formulation reduced partial seizures by 46 percent, while patients taking placebo experienced a reduction of 24 percent over the entire 19-week treatment period. The study also showed significant overall reduction in seizure frequency in both the escalation and maintenance treatment phases. In addition, the study showed that 42 percent of patients treated with Lamictal XR reduced their frequency of seizures by at least half by the end of the 19-week treatment period.

The second study, COMPASS, showed that patients could be switched from Lamictal(R) immediate release (IR) to Lamictal XR while maintaining comparable blood levels of lamotrigine.

"These data are important because they show that the extended release formulation of Lamictal reduces the frequency of seizures. The once daily dosing regimen may also provide a more convenient treatment option for patients," said Dean Naritoku, M.D., Professor of Neurology and Pharmacology, Southern Illinois University, Springfield, IL. "In addition, when compared to Lamictal immediate release, given twice a day, the new investigatio
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
(Date:7/11/2014)... 11, 2014 Patient engagement has become ... organizations are turning to an assortment of marketing ... part of this evolving approach to patient engagement, ... and engage patients throughout their experiences with a ... By mapping the patient journey and employing a ...
(Date:7/11/2014)... 11, 2014  Rock Creek Pharmaceuticals, Inc. (NASDAQ: ... that the Food and Drug Administration ("FDA"), has notified ... RCP,s Investigational New Drug ("IND") application before granting the ... US. Dr. Chris Chapman , RCP,s ... on our IND. When we receive the agency,s official ...
(Date:7/11/2014)... DALLAS , July 11, 2014 ... report "Scintillator Market by Composition of Material, Application ... and others), End Product (Personal Instrument, Hand-Held Instruments, ... Forecast and Analysis to 2013 - 2020", published by MarketsandMarkets, ... a CAGR of 5.62% from 2014 to 2020, ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4
... , , , ... (Nasdaq: AMGN ) today announced the publication of results from ... at reducing fracture risk in more than 7,800 women with postmenopausal osteoporosis ... deprivation therapy (ADT) leading to bone loss. In both studies, published today ...
... , , , ... BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the ... chronically infected with the hepatitis C virus (HCV). The trial, run in ... clemizole monotherapy in the absence of interferon. , , ...
Cached Medicine Technology:Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 2Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 3Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 5Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 6Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 7Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 8Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 9Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 10Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 11Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 2Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 3
(Date:7/11/2014)... (PRWEB) July 11, 2014 Utilizing the ... own, Dr. William Koenig, has topped a record number ... he has performed over 400 successful procedures without the ... Koenig is well known across the country for his ... safety record has long been the foundation for numerous ...
(Date:7/11/2014)... July 11, 2014 (HealthDay News) -- U.S. health officials ... were exposed to live anthrax during a safety mishap ... Control and Prevention officials have announced a moratorium on ... high-level government labs. In a report issued Friday, ... to make sure a similar incident doesn,t occur again. ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 According to ... & Application Market by Communication Technology (ZigBee, Z-Wave, Bluetooth, ... Electronics, Industrial, Automotive & Transportation, Agriculture) & Geography - ... value of Internet of Things market was worth $1029.5 ... Billion by 2020, at an estimated CAGR of 4.08% ...
(Date:7/11/2014)... Toledo, Ohio (PRWEB) July 11, 2014 ... (Morgenson 7/10/14) and FiercePharma (Weintraub 7/11/14), a significant number ... in blood sugar, abdominal issues and even death from ... exposed. , According to the Times report , ... events in 2013 reported by patients was almost 14% ...
(Date:7/11/2014)... NY (PRWEB) July 11, 2014 The ... the five years to 2014 on the heels of ... 2010 prompted farmers to dedicate a larger share of ... production. More specifically, the regulations required the mixing of ... expanding biofuel production in the United States created a ...
Breaking Medicine News(10 mins):Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:CDC Issues Tough Report on Anthrax Scare 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Acthar’s Deadly Adverse Events Revealed 2Health News:Acthar’s Deadly Adverse Events Revealed 3Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3
... announced that it has raised over $20 million in ... raised approximately $15 million through equity contributions by existing ... Intel Capital, Saudi Venture Development Company, Unilever Technology Ventures ... as a new investor. On top of the ...
... Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced that ... of the Year by LifeSciences British Columbia. This ... to recognize an organization that has made outstanding ... sciences industry and to increase public awareness and ...
... Until now, people could expect to need reading glasses ... an aging process called presbyopia. LASIK, a proven technique ... for presbyopia. But today, according to results from a ... M.D., and published in the Journal of Refractive Surgery, ...
... Information Technology CommunitySAN DIEGO and MCLEAN, Va., March 9 ... ) today announced that Federal Computer Week ... leaders who played pivotal roles in the federal information ... individuals from government, industry and academia. Shea and ...
... Bring Specialists Together in Local Meetings and Online; and Help ... the need for long term care insurance grows, agents and ... and with a high level of professionalism. And the public ... area. A new organization will aid the pros as well ...
... KABC-TV Anchor Phillip PalmerLOS ANGELES, March 9 A ... determined the life-or-death fate of kidney patients applying for ... March 12. Produced by Lori Hartwell and the Renal ... transplant recipients R. Martin Klein and Dale Wade Davis, ...
Cached Medicine News:Health News:Surface Logix Raises $20 Million in Financing and Starts Phase 2b Clinical Trial of SLx-4090 in Dyslipidemia and Diabetes 2Health News:Response Biomedical Named Medical Device Company of the Year by LifeSciences British Columbia 2Health News:SAIC's K. Stuart Shea Named Federal 100 Winner by Federal Computer Week 2Health News:Industry Leaders Applaud Formation of Long Term Care Insurance Guild 2Health News:Industry Leaders Applaud Formation of Long Term Care Insurance Guild 3Health News:'Who Lives?' to Open at Pico Playhouse on World Kidney Day This Thursday 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: